Funded startup

Who invested in Medaica

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AIHealthcareHealthtechMedical Devices

Raised this month

Funding summaryUpdated 15 Nov 2026

Undisclosedraised across 1 round since 2026, from 1 source

Latest round
RoundNov 2026
Led by
Zoom Ventures
Investors
1 (1 led)
See who backed them

The rounds

  1. Nov 2026
    RoundAmount undisclosed

    Reported by Pulse 2.0

Funding filed with regulators

Medaica filed 4 raises, $1.3M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. May 2024$330K7 investorsequitySEC Form D
  2. Nov 2022$295K5 investorsdebt, optionsof $1.0M offeredSEC Form D
  3. Jun 2021$300K4 investorsdebt, optionsof $1.0M offeredSEC Form D
  4. Mar 2021$410K3 investorsdebt, optionsof $1.0M offeredSEC Form D

Founders and team

From the SEC filings it signed: 4 on the team.

  • Clive MillingtonExecutive Officer, Directori
  • Mark GrettonExecutive Officer, Directori
  • Pablo RivasExecutive Officer, Directori
  • Stephen RandallExecutive Officer, Directori

On the board, as filediDan Gieschen

Everyone who backed them

Zoom VenturesVC firm1round, led 1

Missing a round, or an investor who was in one? Tell us.

Quick answers about Medaica

Who invested in Medaica?

Medaica's investors include Zoom Ventures. Zoom Ventures led its latest round.

How much has Medaica raised?

Medaica has raised 1 round since 2026, none with a disclosed amount.

When did Medaica last raise?

Medaica's most recent round was in Nov 2026, led by Zoom Ventures.

Who backed Medaica first?

Medaica's first round on record, in Nov 2026, was backed by Zoom Ventures.

Who led Medaica's rounds?

Zoom Ventures led the funding round in 2026.

Companies like Medaica

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.